Emergent Biosolutions EBS Return on assets
Return on assets at other companies
Other financials
Where this comes from
Calculated from Emergent Biosolutions’s reported figures.
Based on trailing twelve months.
The official record: Emergent Biosolutions’s 10-Q, filed October 30, 2025, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's return on assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's return on assets?
- Emergent Biosolutions (EBS) reported return on assets of 5.2% in Q3 2025.
- How has Emergent Biosolutions's return on assets changed year-over-year?
- Emergent Biosolutions's return on assets increased by 141.7% year-over-year, from -12.4% to 5.2%.
- What is the long-term trend for Emergent Biosolutions's return on assets?
- Over 4 years (2020 to 2024), Emergent Biosolutions's return on assets has grown at a 0.3% compound annual growth rate (CAGR), from 11.7% to -11.9%.
- What does return on assets mean?
- Trailing-twelve-month net income divided by average total assets. Measures how efficiently the asset base generates profit, independent of how those assets are financed. Computed as net income over average total assets — note this is OpenCapital's standard definition and may differ from data vendors that use alternative numerators.